Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:1953-1960
Published online before print October 20, 2008, doi: 10.1161/CIRCULATIONAHA.108.789743
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
118/19/1953    most recent
CIRCULATIONAHA.108.789743v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Sadeghi, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Sadeghi, M. M.
Related Collections
Right arrow Remodeling
Right arrow Nuclear cardiology and PET
Right arrow PET and SPECT
Right arrowRelated Article

(Circulation. 2008;118:1953-1960.)
© 2008 American Heart Association, Inc.


Imaging

Molecular Imaging of Activated Matrix Metalloproteinases in Vascular Remodeling

Jiasheng Zhang, MD; Lei Nie, PhD; Mahmoud Razavian, PhD; Masood Ahmed, MD; Lawrence W. Dobrucki, PhD; Abolfazl Asadi, PhD; D. Scott Edwards, PhD; Michael Azure, PhD; Albert J. Sinusas, MD; Mehran M. Sadeghi, MD

From the Raymond and Beverly Sackler Cardiovascular Molecular Imaging Laboratory, Section of Cardiovascular Medicine (J.Z., L.N., M.R., M. Ahmed, L.W.D., A.A., A.J.S., M.M.S.), Yale University School of Medicine, New Haven, Conn; VA Connecticut Healthcare System (J.Z., L.N., M.R., M. Ahmed, A.A., M.M.S.), West Haven, Conn; and Lantheus Medical Imaging (D.S.E., M. Azure), North Billerica, Mass.

Correspondence to Mehran M. Sadeghi, MD, VA Connecticut Healthcare System, 950 Campbell Ave, 111B, West Haven, CT 06516. E-mail Mehran.sadeghi{at}yale.edu

Received April 30, 2008; accepted September 9, 2008.

Background— Matrix metalloproteinase (MMP) activation plays a key role in vascular remodeling. RP782 is a novel indium 111In–labeled tracer with specificity for activated MMPs. We hypothesized that RP782 can detect injury-induced vascular remodeling in vivo.

Methods and Results— Left common carotid artery injury was induced with a guidewire in apolipoprotein E–/– mice. Sham surgery was performed on the contralateral artery, which served as control for imaging experiments. Carotid wire injury led to significant hyperplasia and expansive remodeling over a period of 4 weeks. MMP activity, detected by in situ zymography, increased in response to injury and was maximal by 3 to 4 weeks after injury. RP782 (11.1 MBq) was injected intravenously into apolipoprotein E–/– mice at 1, 2, 3, and 4 weeks after left carotid injury. MicroSPECT imaging was performed at 2 hours and was followed by CT angiography to localize the carotid arteries. In vivo images revealed focal uptake of RP782 in the injured carotid artery at 2, 3, and 4 weeks. Increased tracer uptake in the injured artery was confirmed by quantitative autoradiography. Pretreatment with 50-fold excess nonlabeled tracer significantly reduced RP782 uptake in injured carotids, thus demonstrating uptake specificity. Weekly changes in the vessel-wall area closely paralleled and correlated with RP782 uptake (Spearman r=0.95, P=0.001).

Conclusions— Injury-induced MMP activation in the vessel wall can be detected by RP782 microSPECT/CT imaging in vivo. RP782 uptake tracks the hyperplastic process in vascular remodeling and provides an opportunity to track the remodeling process in vivo.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 118: 1911-1912. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Eur Heart JHome page
C. M. Matter, M. Stuber, and M. Nahrendorf
Imaging of the unstable plaque: how far have we got?
Eur. Heart J., November 1, 2009; 30(21): 2566 - 2574.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Nahrendorf, P. Waterman, G. Thurber, K. Groves, M. Rajopadhye, P. Panizzi, B. Marinelli, E. Aikawa, M. J. Pittet, F. K. Swirski, et al.
Hybrid In Vivo FMT-CT Imaging of Protease Activity in Atherosclerosis With Customized Nanosensors
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1444 - 1451.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
R. Lautamaki, K. H. Schuleri, T. Sasano, M. S. Javadi, A. Youssef, J. Merrill, S. G. Nekolla, M. R. Abraham, A. C. Lardo, and F. M. Bengel
Integration of Infarct Size, Tissue Perfusion, and Metabolism by Hybrid Cardiac Positron Emission Tomography/Computed Tomography: Evaluation in a Porcine Model of Myocardial Infarction
Circ Cardiovasc Imaging, July 1, 2009; 2(4): 299 - 305.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging, January 1, 2009; 2(1): 56 - 70.
[Full Text] [PDF]